Tarsadia Capital employs a flexible, long-duration investment mandate across public and private equities and commodities globally, utilizing a multi-strategy approach that includes venture and growth equity, life sciences, and real estate. The firm is thesis-driven, seeking to partner with companies from Series A and beyond that are tackling systemic problems in large markets, often focusing on sectors like Healthtech, Fintech, DeepTech, and Life Sciences.
36% of their portfolio is in Fintech. They made 2 investments in the last 12 months. Average disclosed round size is $164.6M (across 11 rounds with reported amounts).
Portfolio
14
Fund Size
$2B
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CClinTrial Research | Growth | — | Dec 2025 |
| MMatterworks, Inc. | Series A | — | Jun 2025 |
 Chronus Health | Series A | $22M | Jan 2022 |
 Petal | Series D | $140M | Jan 2022 |
 AvantStay | Series B | $160M | Dec 2021 |
 bolttech | Series A | $180M | Jul 2021 |
 Yieldstreet | Series C | $100M | Jun 2021 |
 Loft | Series D | $425M | Mar 2021 |
 Phil Inc. | Series B | $25M | May 2019 |
 Horizn Studios | Series B | — | Jan 2019 |
| JJüsto | Series B | $152M | — |
| DDaqri | Series D | $275M | — |
 Creditas | Series E | $255M | — |
| Yieldstreet | Unknown | $77M | — |
Top Co-Investors
Soros Fund Management3 shared
Gaingels3 shared
Kingfisher Investment Advisors2 shared
Top Tier Capital Partners2 shared
Edison Partners2 shared
Greenspring Associates2 shared
The Raine Group2 shared
Greycroft2 shared
General Atlantic1 shared
Foundation Capital1 shared
Quiet Capital1 shared
Pillar VC1 shared
Germin81 shared
LGT Lightstone1 shared
e.ventures1 shared
Sunley House Capital1 shared
Altimeter Capital1 shared
Tiger Global Management1 shared
Andreessen Horowitz1 shared
DST Global1 shared
Last updated: 16 April 2026